A phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus
…, A James Loftis, P Alabanza, F Lipansky… - Science translational …, 2021 - science.org
There is an urgent need for an effective, oral, direct-acting therapeutic to block transmission
of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and prevent progression …
of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and prevent progression …
Molnupiravir, an oral antiviral treatment for COVID-19
…, DA Wohl, AJ Loftis, P Alabanza, F Lipansky… - MedRxiv, 2021 - medrxiv.org
Background Easily distributed oral antivirals are urgently needed to treat coronavirus
disease-2019 (COVID-19), prevent progression to severe illness, and block transmission of severe …
disease-2019 (COVID-19), prevent progression to severe illness, and block transmission of severe …
The Antiviral Mechanism of Action of Molnupiravir in Humans with COVID-19
…, JD Chappell, AJ Brown, J Won, F Lipansky… - medRxiv, 2023 - medrxiv.org
Meaningful metrics of antiviral activity are essential for determining the efficacy of therapeutics
in human clinical trials. Molnupiravir (MOV) is a broadly acting antiviral nucleoside analog …
in human clinical trials. Molnupiravir (MOV) is a broadly acting antiviral nucleoside analog …
Development and validation of assays for the quantification of β-D-N4-hydroxycytidine in human plasma and β-D-N4-hydroxycytidine-triphosphate in peripheral blood …
TL Parsons, LA Kryszak, MA Marzinke - Journal of Chromatography B, 2021 - Elsevier
… We gratefully acknowledge Wendy Painter, Merribeth Morin, Felicia Lipansky, and Wendy
Lin at Ridgeback Biotherapeutics for the generous provision of drug compounds and internal …
Lin at Ridgeback Biotherapeutics for the generous provision of drug compounds and internal …
Safety and immunogenicity of a novel quadrivalent meningococcal CRM-conjugate vaccine given concomitantly with routine vaccinations in infants
NP Klein, KS Reisinger, W Johnston… - The Pediatric …, 2012 - journals.lww.com
Background: In phase II studies, MenACWY-CRM elicited robust immunologic responses in
young infants. We now present results from our pivotal phase III infant immunogenicity/safety …
young infants. We now present results from our pivotal phase III infant immunogenicity/safety …
[BOOK][B] Learning to fly: The transformative aspects of the rave experience
D Sherk - 2010 - search.proquest.com
The phenomenon of the post-modern rave experience and its parallels to ancient Eastern
traditions and practices are presented in this artistic-creative production thesis. A heuristic …
traditions and practices are presented in this artistic-creative production thesis. A heuristic …
A Selective Review of Both Public Health and Economic Perspectives on the COVID-19 Pandemic
FC Lai, WC Chen, CW Chen… - Jing Ji Lun Wen Cong …, 2023 - search.proquest.com
This paper selectively reviews the public health and economic perspectives on the COVID-19
pandemic in mainstream academic journals since the outbreak of the pandemic. We first …
pandemic in mainstream academic journals since the outbreak of the pandemic. We first …
[PDF][PDF] Nové karbocyklické nukleosidové analogy–potenciální inhibitory methyltransferáz
P POSPÍŠIL - is.muni.cz
… AZIZAD, Katyna BORROTO-ESODA, David A WOHL, Amy James LOFTIS, Paul ALABANZA,
Felicia LIPANSKY a Wendy P. PAINTER. Molnupiravir, an Oral Antiviral Treatment for COVID…
Felicia LIPANSKY a Wendy P. PAINTER. Molnupiravir, an Oral Antiviral Treatment for COVID…
[CITATION][C] The Antiviral Mechanism of Action of Molnupiravir in Humans with COVID-19 (preprint)
…, JD Chappell, AJ Brown, J Won, F Lipansky… - 2023
[CITATION][C] INVESTIGATIONAL DRUG SYMPOSIUM, FRIDAY APRIL 28, 2017
J Howard, MD Claire, MD Hemmaway, MDM Layton… - JSCDH-D-17-00018: Changes in …
